Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Analysts Estimate Helmerich & Payne (HP) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Helmerich & Payne (HP) to Report a Decline in Earnings: What to Look Out for

The market expects Helmerich & Payne (HP) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known

TEGNA (TGNA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
TEGNA (TGNA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

TEGNA Inc. (TGNA) reported $650.79 million in revenue for the quarter ended September 2025, representing a year-over-year decline of 19.3%. EPS of $0.33 for the same period compares to $0.94 a year

Wall Street Analysts Believe Amicus Therapeutics (FOLD) Could Rally 76.32%: Here's is How to Trade
Wall Street Analysts Believe Amicus Therapeutics (FOLD) Could Rally 76.32%: Here's is How to Trade

Amicus Therapeutics (FOLD) closed the last trading session at $8.87, gaining 6.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Wall Street Analysts Think GH Research (GHRS) Could Surge 130.59%: Read This Before Placing a Bet
Wall Street Analysts Think GH Research (GHRS) Could Surge 130.59%: Read This Before Placing a Bet

GH Research PLC (GHRS) closed the last trading session at $13.5, gaining 7.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Predict an 80.58% Upside in CorMedix (CRMD): Here's  What You Should Know
Wall Street Analysts Predict an 80.58% Upside in CorMedix (CRMD): Here's What You Should Know

CorMedix (CRMD) closed the last trading session at $10.76, gaining 0.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Wall Street Analysts Think Conmed (CNMD) Could Surge 25.54%: Read This Before Placing a Bet
Wall Street Analysts Think Conmed (CNMD) Could Surge 25.54%: Read This Before Placing a Bet

Shares of Conmed (CNMD) have gained 3% over the past four weeks to close the last trading session at $43.97, but there could still be a solid upside left in the stock if short-term price targets of

Wall Street Analysts See a 50.76% Upside in GRINDR INC (GRND): Can the Stock Really Move This High?
Wall Street Analysts See a 50.76% Upside in GRINDR INC (GRND): Can the Stock Really Move This High?

Shares of Grindr Inc. (GRND) have gained 26.2% over the past four weeks to close the last trading session at $15.09, but there could still be a solid upside left in the stock if short-term price

Wall Street Analysts Believe Encore Capital Group (ECPG) Could Rally 27.35%: Here's is How to Trade
Wall Street Analysts Believe Encore Capital Group (ECPG) Could Rally 27.35%: Here's is How to Trade

Shares of Encore Capital Group (ECPG) have gained 12.7% over the past four weeks to close the last trading session at $47.31, but there could still be a solid upside left in the stock if short-term

Does Crexendo (CXDO) Have the Potential to Rally 33.63% as Wall Street Analysts Expect?
Does Crexendo (CXDO) Have the Potential to Rally 33.63% as Wall Street Analysts Expect?

Crexendo (CXDO) closed the last trading session at $6.66, gaining 12.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Does Abacus Life, Inc. (ABL) Have the Potential to Rally 103.1% as Wall Street Analysts Expect?
Does Abacus Life, Inc. (ABL) Have the Potential to Rally 103.1% as Wall Street Analysts Expect?

Abacus Life, Inc. (ABL) closed the last trading session at $6.45, gaining 12.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Wall Street Analysts Predict a 30.54% Upside in ScanSource (SCSC): Here's  What You Should Know
Wall Street Analysts Predict a 30.54% Upside in ScanSource (SCSC): Here's What You Should Know

ScanSource (SCSC) closed the last trading session at $40.6, gaining 0.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Believe Vericel (VCEL) Could Rally 39.42%: Here's is How to Trade
Wall Street Analysts Believe Vericel (VCEL) Could Rally 39.42%: Here's is How to Trade

Vericel Corporation (VCEL) closed the last trading session at $38.94, gaining 22.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Wall Street Analysts See a 26.85% Upside in Controladora Vuela (VLRS): Can the Stock Really Move This High?
Wall Street Analysts See a 26.85% Upside in Controladora Vuela (VLRS): Can the Stock Really Move This High?

Controladora Vuela (VLRS) closed the last trading session at $6.63, gaining 0.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

Wall Street Analysts Believe Waystar (WAY) Could Rally 38.21%: Here's is How to Trade
Wall Street Analysts Believe Waystar (WAY) Could Rally 38.21%: Here's is How to Trade

Waystar Holding (WAY) closed the last trading session at $36.22, gaining 1.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Think Slide Insurance Holdings, Inc. (SLDE) Could Surge 33.73%: Read This Before Placing a Bet
Wall Street Analysts Think Slide Insurance Holdings, Inc. (SLDE) Could Surge 33.73%: Read This Before Placing a Bet

Slide Insurance Holdings, Inc. (SLDE) closed the last trading session at $16.6, gaining 6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Wall Street Analysts Think Ultra Clean (UCTT) Could Surge 34.31%: Read This Before Placing a Bet
Wall Street Analysts Think Ultra Clean (UCTT) Could Surge 34.31%: Read This Before Placing a Bet

Shares of Ultra Clean Holdings (UCTT) have gained 2.1% over the past four weeks to close the last trading session at $26.06, but there could still be a solid upside left in the stock if short-term

Wall Street Analysts See a 42.78% Upside in Keros Therapeutics (KROS): Can the Stock Really Move This High?
Wall Street Analysts See a 42.78% Upside in Keros Therapeutics (KROS): Can the Stock Really Move This High?

Keros Therapeutics, Inc. (KROS) closed the last trading session at $16.2, gaining 3.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Does Pharming Group (PHAR) Have the Potential to Rally 100.91% as Wall Street Analysts Expect?
Does Pharming Group (PHAR) Have the Potential to Rally 100.91% as Wall Street Analysts Expect?

Shares of Pharming Group N.V. Sponsored ADR (PHAR) have gained 8.1% over the past four weeks to close the last trading session at $15.43, but there could still be a solid upside left in the stock if

Wall Street Analysts Believe PRA Group (PRAA) Could Rally 53.69%: Here's is How to Trade
Wall Street Analysts Believe PRA Group (PRAA) Could Rally 53.69%: Here's is How to Trade

Shares of PRA Group (PRAA) have gained 10.1% over the past four weeks to close the last trading session at $14.75, but there could still be a solid upside left in the stock if short-term price

Wall Street Analysts See a 75.15% Upside in Orion Energy Systems (OESX): Can the Stock Really Move This High?
Wall Street Analysts See a 75.15% Upside in Orion Energy Systems (OESX): Can the Stock Really Move This High?

Orion Energy Systems, Inc. (OESX) closed the last trading session at $10.18, gaining 26.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Wall Street Analysts Predict a 35.5% Upside in SkyWest (SKYW): Here's  What You Should Know
Wall Street Analysts Predict a 35.5% Upside in SkyWest (SKYW): Here's What You Should Know

SkyWest (SKYW) closed the last trading session at $98.6, gaining 1.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Here's Why Schrodinger (SDGR) Is a Great 'Buy the Bottom' Stock Now
Here's Why Schrodinger (SDGR) Is a Great 'Buy the Bottom' Stock Now

A downtrend has been apparent in Schrodinger, Inc. (SDGR) lately. While the stock has lost 15.5% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its

Does Chime Financial, Inc. (CHYM) Have the Potential to Rally 52.06% as Wall Street Analysts Expect?
Does Chime Financial, Inc. (CHYM) Have the Potential to Rally 52.06% as Wall Street Analysts Expect?

Shares of Chime Financial, Inc. (CHYM) have gained 3.9% over the past four weeks to close the last trading session at $20.34, but there could still be a solid upside left in the stock if short-term

Does Onestream (OS) Have the Potential to Rally 25.9% as Wall Street Analysts Expect?
Does Onestream (OS) Have the Potential to Rally 25.9% as Wall Street Analysts Expect?

Shares of Onestream (OS) have gained 28.3% over the past four weeks to close the last trading session at $22.74, but there could still be a solid upside left in the stock if short-term price targets

Wall Street Analysts Predict a 45.88% Upside in OppFi (OPFI): Here's  What You Should Know
Wall Street Analysts Predict a 45.88% Upside in OppFi (OPFI): Here's What You Should Know

Shares of OppFi Inc. (OPFI) have gained 3.2% over the past four weeks to close the last trading session at $9.94, but there could still be a solid upside left in the stock if short-term price